Phase Capital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://phasecapital.co
- HQ
- TN
Phase Capital is a venture firm that invests in technology-first, revenue-generating companies at the intersection of AI, biology, and proprietary data. It focuses on the adaptive data layer of biotech. The firm's team includes Managing Partner Kavya Sharman, Partner Kristen Johns, Analyst Abigail Harris, Executive Assistant Kristan Lemmons, and Senior Venture Fellow Elena Solopova.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Pre-seed, Seed, Series A | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | US | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Phase Capital Fund I LP Phase Capital invests in technology-first, revenue-generating companies at pre-seed to Series A at the intersection of AI, biology, and proprietary data. It focuses on the adaptive data layer of biotech, backing platforms that continuously generate proprietary biological data. Inferred from the firm's website | approx. 2025 | $30M (Form D) | Raising |
03 · People across funds
- Kavya Sharman, Manager of the General Partner of the Issuer
Phase Capital Fund I LP (Named on Form D)
- Abigail Harris, Analyst
Phase Capital Fund I LP (Team)
- Elena Solopova, Senior Venture Fellow
Phase Capital Fund I LP (Team)
- Kavya Sharman, PhD, Managing Partner
Phase Capital Fund I LP (Team)
- Kristan Lemmons, Executive Assistant
Phase Capital Fund I LP (Team)
- Kristen Johns, JD, Partner
Phase Capital Fund I LP (Team)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026